Broome, C., Hsu, D., Choi, P., Zhou, C., Mozaffarian, N. (2025). Trial in progress: A phase 1b, open-label, multiple ascending dose study of OM336, a novel BCMAxCD3 T cell engager, in patients with relapsed/refractory autoimmune cytopenias (NCT07083960). Blood. https://doi.org/10.1182/blood-2025-2900